Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tougeron

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 30, 2022
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trialClélia Coutzac, Frederic Bibeau, Meher Ben Abdelghani, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2023
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective studyJean-Baptiste Bachet, Pierre Laurent-Puig, Aurelia Meurisse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEPChristelle de la Fouchardière, Aziz Zaanan, Aymeric de Montfort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II TrialMaximiliano Gelli, Jacques Ewald, Marie-Laure Tanguy, et al.
British Journal of Cancer|January 6, 2024
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASEClaire Gouriou, Claire Lemanski, Pascal Pommier, et al.
NPJ Precision Oncology|June 26, 2026
Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary studyAlix Mérigout, Emmanuelle Samalin, Anthony Turpin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 28, 2020
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancerCamille Evrard, Christophe Louvet, Farid El Hajbi, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)Marine Valery, Julien Edeline, Julie Henriques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2023
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) StudySebastian Stintzing, Kathrin Heinrich, David Tougeron, et al.
Cancers|July 20, 2019
<i>BRAF</i> Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC StudyLeo Mas, Jean-Baptiste Bachet, Valerie Taly, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 30, 2022
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trialClélia Coutzac, Frederic Bibeau, Meher Ben Abdelghani, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2023
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective studyJean-Baptiste Bachet, Pierre Laurent-Puig, Aurelia Meurisse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEPChristelle de la Fouchardière, Aziz Zaanan, Aymeric de Montfort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II TrialMaximiliano Gelli, Jacques Ewald, Marie-Laure Tanguy, et al.
British Journal of Cancer|January 6, 2024
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASEClaire Gouriou, Claire Lemanski, Pascal Pommier, et al.
NPJ Precision Oncology|June 26, 2026
Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary studyAlix Mérigout, Emmanuelle Samalin, Anthony Turpin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 28, 2020
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancerCamille Evrard, Christophe Louvet, Farid El Hajbi, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)Marine Valery, Julien Edeline, Julie Henriques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2023
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) StudySebastian Stintzing, Kathrin Heinrich, David Tougeron, et al.
Cancers|July 20, 2019
<i>BRAF</i> Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC StudyLeo Mas, Jean-Baptiste Bachet, Valerie Taly, et al.
Pageof 24